Interview by Monika Duszyńska
Interview by Monika Duszyńska for the Polish Society of Gynecologic Oncology Interview
Shortlisted for the Life Sciences Law Firm of 2020 – LMG Life Sciences
Our law firm has been shortlisted for the title of Life Sciences Law Firm of the Year in Poland, according to the international LMG Life Sciences legal ranking. We are very grateful for the received recognition and such a good feedback on the legal services provided by us.
Third place in Legal 500 EMEA 2020
We are proud and happy to share the news that our law firm Monika Duszyńska Law for Lifesciences has been ranked in Tier 3 of this year edition of Legal 500, EMEA 2020, in Healthcare and Life Sciences. We are particularly honoured by the testimonials that were given on our work and commitment. „Monika Duszyńska [...]
Monika Duszyńska as co-author of the report “Proposal of a new mechanism for early and conditional access to anticancer and innovative drug technologies (WDTL+)” GalleryMonika Duszyńska as co-author of the report “Proposal of a new mechanism for early and conditional access to anticancer and innovative drug technologies (WDTL+)”
Monika Duszyńska as co-author of the report “Proposal of a new mechanism for early and conditional access to anticancer and innovative drug technologies (WDTL+)”
The research project prepared by Lazarski University presents a proposal for a new solution to improve Polish patients' access to modern drug technologies, in particular in the treatment of cancer. The report discusses the advantages and limitations of existing international and Polish solutions, presents the results of cost and value analyzes of drug technologies, and [...]
Chambers&Partners Europe 2020
In 2020 edition of Chambers&Partners Europe international legal ranking, Lifesciences, Monika is ranked in Band II as an individual lawyer. Chambers&Partners reports: MONIKA DUSZYŃSKA has a remit encompassing unfair competition cases, distribution agreements, reimbursement and advertising issues for pharmaceutical companies and patient organisations. Clients praise her for her skill in cases concerning medical devices, one [...]
Workshop for patients’ organizations – HTA in Poland and The European Union
On January 27, 2020, Monika Duszyńska was a lecturer at a workshop on health technology assessment - HTA in Poland and the European Union. The meeting organized by the Polish Coalition of Cancer Patients was attended by 26 representatives of 16 cancer patients’ organizations from all over Poland. The purpose of the workshop was to [...]
Monika advises on the reimbursement of the costs of treatment obtained outside Poland
Monika advised the parents of a newborn with rare heart disorders in proceedings concerning reimbursement from the National Health Fund of the costs of very complicated surgery treatment obtained abroad (several hundred thousand zlotys). The President of the NFZ (National Health Fund) approved the reimbursement of these costs in full.
Monika as one of the authors of IZWOZ reports
Monika Duszyńska is one of the authors of the extensive report published by the Institute of Health Management at Lazarski University. "Reasons of a limited availability of medicines in Poland. Diagnosis and proposed solutions” is a detailed analysis of restricted market availability of certain medicines and suggests a number of potential solutions, in particular in [...]
The report “Costs of new drug technologies in the treatment of the most commonly diagnosed cancers. Forecast 2019-2021
Monika Duszyńska is one of the authors of the report ‘Costs of new drug technologies in the treatment of the most commonly diagnosed cancers. Forecast 2019-2021’ prepared by the Institute of Health Management at Lazarski University. The report defines goals and tools required for an effective implementation of the health policy in the area of [...]
Conference Biological Medicines – legal aspects at UKSW
In December 2019 took place an annual nationwide scientific conference, organized by UKSW University in Warsaw, faculty of Law and Administration. Monika Duszyńska led the first panel, entitled „Patient under a biological treatment’’. The panel was attended, among others, by Prof. Marcin Czech and Paweł Grzesiewski, Director of Legal Affairs at the office of the [...]